(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
| Title | Journal |
|---|---|
| Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study. | Scientific reports 20160101 |
| Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. | CNS drugs 20140101 |
| Cognitive enhancement as a treatment for drug addictions. | Neuropharmacology 20130101 |
| Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. | Neuropharmacology 20130101 |
| Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. | CNS drugs 20130101 |
| Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. | The international journal of neuropsychopharmacology 20121101 |
| A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples. | Biomedical chromatography : BMC 20121101 |
| Atomoxetine use during a period of FDA actions. | Medical care 20121101 |
| Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. | Applied health economics and health policy 20121101 |
| Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia. | Current neurology and neuroscience reports 20121001 |
| Candida tenuis xylose reductase catalyzed reduction of aryl ketones for enantioselective synthesis of active oxetine derivatives. | Chirality 20121001 |
| Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology. | Journal of clinical psychopharmacology 20121001 |
| Current pharmacotherapy options for bulimia nervosa and binge eating disorder. | Expert opinion on pharmacotherapy 20121001 |
| Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder. | Child and adolescent psychiatric clinics of North America 20121001 |
| A practical guide to the therapy of narcolepsy and hypersomnia syndromes. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20121001 |
| Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20121001 |
| Potential serious adverse interactions between linezolid and atomoxetine. | Journal of child and adolescent psychopharmacology 20121001 |
| The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. | Molecular psychiatry 20120901 |
| Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. | Archives of general psychiatry 20120901 |
| Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations. | Postgraduate medicine 20120901 |
| Variable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats. | Neuroscience 20120830 |
| Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. | Neuroscience letters 20120830 |
| Noradrenergic modulation of human visual cortex excitability assessed by paired-pulse visual-evoked potentials. | Neuroreport 20120822 |
| Norepinephrine and dopamine modulate impulsivity on the five-choice serial reaction time task through opponent actions in the shell and core sub-regions of the nucleus accumbens. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120801 |
| Review: methylphenidate and atomoxetine have similar efficacy and acceptability in children and adolescents with ADHD. | Evidence-based mental health 20120801 |
| Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder. | CNS drugs 20120801 |
| Atomoxetine improves communication in a girl with semantic-pragmatic disorder. | Pediatrics international : official journal of the Japan Pediatric Society 20120801 |
| Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. | Journal of child and adolescent psychopharmacology 20120801 |
| Treatment practices in Tourette syndrome: the European perspective. | European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20120701 |
| A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20120701 |
| A population-based study of stimulant drug treatment of ADHD and academic progress in children. | Pediatrics 20120701 |
| Pharmacotherapy of autonomic failure. | Pharmacology & therapeutics 20120601 |
| Delays in psychiatric drug development in Japan. | Journal of clinical pharmacy and therapeutics 20120601 |
| Attention-deficit/hyperactivity disorder among children and adolescents in the United States: trend in diagnosis and use of pharmacotherapy by gender. | Clinical pediatrics 20120601 |
| Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist. | The AAPS journal 20120601 |
| Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | Journal of medicinal chemistry 20120524 |
| The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats. | European journal of pharmacology 20120515 |
| Development and validation of a liquid chromatography-tandem mass spectrometry assay for hair analysis of atomoxetine and its metabolites: Application in clinical practice. | Forensic science international 20120510 |
| How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis. | Journal of attention disorders 20120501 |
| The ethics of elective psychopharmacology. | The international journal of neuropsychopharmacology 20120501 |
| A close eye on the eagle-eyed visual acuity hypothesis of autism. | Journal of autism and developmental disorders 20120501 |
| A randomized, waiting list-controlled 12-week trial of atomoxetine in adults with ADHD. | Pharmacopsychiatry 20120501 |
| Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses. | Drug metabolism and disposition: the biological fate of chemicals 20120501 |
| Treatment of dual diagnosis disorders. | Current opinion in psychiatry 20120501 |
| Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. | Expert opinion on drug metabolism & toxicology 20120501 |
| Treating ADHD with agomelatine. | Journal of attention disorders 20120501 |
| Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. | CNS drugs 20120501 |
| Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. | Pharmacoepidemiology and drug safety 20120501 |
| Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test. | Progress in neuro-psychopharmacology & biological psychiatry 20120427 |
| Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120417 |
| Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. | NeuroImage 20120402 |
| Effects of atomoxetine on cardiovascular functions and on QT dispersion in children with attention deficit hyperactivity disorder. | Cardiology in the young 20120401 |
| How informative is a negative finding in a small pharmacogenetic study? | The pharmacogenomics journal 20120401 |
| An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD. | The Journal of clinical psychiatry 20120401 |
| Atomoxetine for encopresis in 2 children with attention-deficit/hyperactivity disorder. | Journal of clinical psychopharmacology 20120401 |
| Pharmacokinetics, safety, and tolerability of atomoxetine and effect of CYP2D6*10/*10 genotype in healthy Japanese men. | Journal of clinical pharmacology 20120301 |
| [Stimulant and non-stimulant medication in current and future therapy for ADHD]. | Fortschritte der Neurologie-Psychiatrie 20120301 |
| Reported paediatric adverse drug reactions in the UK 2000-2009. | British journal of clinical pharmacology 20120301 |
| Compound stimulus presentation and the norepinephrine reuptake inhibitor atomoxetine enhance long-term extinction of cocaine-seeking behavior. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120301 |
| The change of the cortisol levels in children with ADHD treated by methylphenidate or atomoxetine. | Journal of psychiatric research 20120301 |
| Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials. | Attention deficit and hyperactivity disorders 20120301 |
| Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure. | Hypertension (Dallas, Tex. : 1979) 20120301 |
| New therapies for postural hypotension. | Hypertension (Dallas, Tex. : 1979) 20120301 |
| Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. | Academic pediatrics 20120301 |
| Management of attention-deficit disorder and attention-deficit/hyperactivity disorder drug intoxication in dogs and cats. | The Veterinary clinics of North America. Small animal practice 20120301 |
| Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry. | Journal of pharmaceutical and biomedical analysis 20120223 |
| Neurochemical enhancement of conscious error awareness. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120222 |
| Determination of atomoxetine metabolites in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120215 |
| The use of dopaminergic and stimulant drugs for the treatment of depression. | Journal of psychosocial nursing and mental health services 20120201 |
| Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis. | Clinical therapeutics 20120201 |
| The need to develop more sensitive tools to accurately detect clinical response to treatment in ADHD. | CNS drugs 20120201 |
| Methylphenidate and risk of serious cardiovascular events in adults. | The American journal of psychiatry 20120201 |
| Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder. | Vojnosanitetski pregled 20120201 |
| The noradrenaline reuptake inhibitor atomoxetine phase-shifts the circadian clock in mice. | Neuroscience 20120110 |
| Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. | Psychological medicine 20120101 |
| Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. | Psychopharmacology 20120101 |
| On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. | Psychopharmacology 20120101 |
| Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks. | Psychopharmacology 20120101 |
| Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex. | Psychopharmacology 20120101 |
| The influence of sex-linked genetic mechanisms on attention and impulsivity. | Biological psychology 20120101 |
| Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. | Psychopharmacology 20120101 |
| A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance? | Child and adolescent psychiatry and mental health 20120101 |
| The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. | Parkinson's disease 20120101 |
| Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology. | Frontiers in pharmacology 20120101 |
| Pattern recognition and functional neuroimaging help to discriminate healthy adolescents at risk for mood disorders from low risk adolescents. | PloS one 20120101 |
| Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers. | Annals of general psychiatry 20120101 |
| [Use of psychotropic agents for children with psychosomatic problems and developmental disorders]. | Nihon rinsho. Japanese journal of clinical medicine 20120101 |
| The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit/hyperactivity disorder (ADHD) and healthy controls. | PloS one 20120101 |
| Update on the role of antipsychotics in the treatment of Tourette syndrome. | Neuropsychiatric disease and treatment 20120101 |
| A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand. | BMJ open 20120101 |
| Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice. | PloS one 20120101 |
| Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics. | International journal of Alzheimer's disease 20120101 |
| [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)]. | Duodecim; laaketieteellinen aikakauskirja 20120101 |
| How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD. | ISRN pharmacology 20120101 |
| Differential brain development with low and high IQ in attention-deficit/hyperactivity disorder. | PloS one 20120101 |
| Age-related neurodegeneration and memory loss in down syndrome. | Current gerontology and geriatrics research 20120101 |
| Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning. | Clinical neuropharmacology 20120101 |
| MRI study on the functional and spatial consistency of resting state-related independent components of the brain network. | Korean journal of radiology 20120101 |
| The relationship between impulsive choice and impulsive action: a cross-species translational study. | PloS one 20120101 |
| Treatment-resistant Schizophrenia: Evidence-based Strategies. | Mens sana monographs 20120101 |
| Drug therapy of attention deficit hyperactivity disorder: current trends. | Mens sana monographs 20120101 |
| Pharmacological management of binge eating disorder: current and emerging treatment options. | Therapeutics and clinical risk management 20120101 |
| Optimal treatment of social phobia: systematic review and meta-analysis. | Neuropsychiatric disease and treatment 20120101 |
| The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. | BMC pediatrics 20120101 |
| The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. | Innovations in clinical neuroscience 20120101 |
| Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants. | European journal of pharmacology 20111230 |
| ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. | JAMA 20111228 |
| The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. | CNS neuroscience & therapeutics 20111201 |
| Improvement in global psychopathology increases quality of life during treatment of ADHD with atomoxetine or stimulants. | The Psychiatric quarterly 20111201 |
| Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study. | Attention deficit and hyperactivity disorders 20111201 |
| Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials. | Attention deficit and hyperactivity disorders 20111201 |
| Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. | Current medical research and opinion 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of α2 adrenergic receptors. | Brain research bulletin 20111125 |
| Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study. | Journal of attention disorders 20111101 |
| Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. | Journal of attention disorders 20111101 |
| Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. | Pharmacology, biochemistry, and behavior 20111101 |
| Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. | PLoS medicine 20111101 |
| Spectrophotometric and spectrofluorimetric determination of atomoxetine in pharmaceutical preparations. | Die Pharmazie 20111101 |
| [Atomoxetine in ADHD: caution]. | La Revue du praticien 20111101 |
| One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder. | European journal of clinical pharmacology 20111001 |
| Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. | Environmental health perspectives 20111001 |
| Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD. | European child & adolescent psychiatry 20111001 |
| An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. | European child & adolescent psychiatry 20111001 |
| An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety. | European child & adolescent psychiatry 20111001 |
| Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence. | European child & adolescent psychiatry 20111001 |
| Atomoxetine facilitates attentional set shifting in adolescent rats. | Developmental cognitive neuroscience 20111001 |
| Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. | Journal of the American Academy of Child and Adolescent Psychiatry 20111001 |
| Methylphenidate: growth retardation. | Prescrire international 20111001 |
| The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20111001 |
| Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. | Journal of child and adolescent psychopharmacology 20111001 |
| Successful treatment of early ropivacaine toxicity with intralipid in a patient with attention deficit hyperactivity disorder. | Middle East journal of anaesthesiology 20111001 |
| Conditioned place preference studies with atomoxetine in an animal model of ADHD: effects of previous atomoxetine treatment. | European journal of pharmacology 20110930 |
| Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder. | Acta paediatrica (Oslo, Norway : 1992) 20110901 |
| Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. | Attention deficit and hyperactivity disorders 20110901 |
| No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample. | Attention deficit and hyperactivity disorders 20110901 |
| Is there potential for the treatment of children with ADHD beyond psychostimulants? | European child & adolescent psychiatry 20110901 |
| Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults. | CNS drugs 20110901 |
| Pragmatic measures in paediatric psychopharmacology--are we getting it right? | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110801 |
| Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. | Pharmacology, biochemistry, and behavior 20110801 |
| Cognitive enhancers for the treatment of ADHD. | Pharmacology, biochemistry, and behavior 20110801 |
| Adding 8 weeks of behavioural therapy to atomoxetine does not improve classroom behaviour in children with ADHD. | Evidence-based mental health 20110801 |
| Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. | Journal of pediatric gastroenterology and nutrition 20110801 |
| Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge. | CNS drugs 20110701 |
| Prefrontal and monoaminergic contributions to stop-signal task performance in rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110622 |
| Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. | Biological psychiatry 20110615 |
| Catecholamine influences on dorsolateral prefrontal cortical networks. | Biological psychiatry 20110615 |
| The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. | Biological psychiatry 20110615 |
| Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20110601 |
| Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. | Child psychiatry and human development 20110601 |
| Apathy and Parkinson's disease. | Current treatment options in neurology 20110601 |
| Cardiovascular events and death in children exposed and unexposed to ADHD agents. | Pediatrics 20110601 |
| Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder. | CNS drugs 20110601 |
| Idiosyncratic liver failure probably associated with atomoxetine: a case report. | Journal of child and adolescent psychopharmacology 20110601 |
| A randomized, open-label assessment of response to various doses of atomoxetine in korean pediatric outpatients with attention-deficit/hyperactivity disorder. | Psychiatry investigation 20110601 |
| Atomoxetine and myocardial infarction. | Southern medical journal 20110601 |
| Academic outcomes in Asian children aged 8-11 years with attention-deficit/hyperactivity disorder treated with atomoxetine hydrochloride. | International journal of psychiatry in clinical practice 20110601 |
| Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins. | Neurotoxicity research 20110501 |
| Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates. | NeuroImage 20110501 |
| Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. | Biological psychiatry 20110501 |
| Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. | Biological psychiatry 20110501 |
| Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. | Menopause (New York, N.Y.) 20110501 |
| Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110501 |
| ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD. | Pharmacology, biochemistry, and behavior 20110501 |
| Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine. | Medical hypotheses 20110501 |
| [Autism and ADHD across the life span. Differential diagnoses or comorbidity?]. | Der Nervenarzt 20110501 |
| Drugs for treatment of ADHD. | Treatment guidelines from the Medical Letter 20110501 |
| [Effectiveness and safety of methylphenidate and atomoxetine for attention deficit hyperactivity disorder: a systematic review]. | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20110501 |
| Promising medications for cocaine dependence treatment. | Recent patents on CNS drug discovery 20110501 |
| Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders. | The Cochrane database of systematic reviews 20110413 |
| A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. | Pediatrics 20110401 |
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. | European child & adolescent psychiatry 20110401 |
| Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. | Clinical schizophrenia & related psychoses 20110401 |
| Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD. | Expert review of neurotherapeutics 20110401 |
| Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. | Journal of child and adolescent psychopharmacology 20110401 |
| A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent Crone-Renkin equation. | Pharmaceutical research 20110301 |
| [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder]. | Revista de neurologia 20110301 |
| [Alcoholic foetopathy: an update]. | Revista de neurologia 20110301 |
| Risks and benefits of available treatments for adult ADHD. | The Journal of clinical psychiatry 20110301 |
| Are Teacher Ratings and Parent Ratings Differently Associated with Children's Intelligence and Cognitive Performance? | Psychiatry investigation 20110301 |
| Effect of atomoxetine on executive function impairments in adults with ADHD. | Journal of attention disorders 20110201 |
| Changes in emotions related to medication used to treat ADHD. Part I: literature review. | Journal of attention disorders 20110201 |
| Response requirement and increases in accuracy produced by stimulant drugs in a 5-choice serial reaction-time task in rats. | Psychopharmacology 20110201 |
| Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking. | Biological psychiatry 20110201 |
| Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure. | Neuroscience letters 20110201 |
| ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study. | Journal of neural transmission (Vienna, Austria : 1996) 20110201 |
| Atomoxetine-induced myocardial infarction. | Southern medical journal 20110201 |
| An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder. | Psychiatry and clinical neurosciences 20110201 |
| Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. | Pediatric clinics of North America 20110201 |
| A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20110201 |
| Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. | Clinical therapeutics 20110201 |
| Changes of urine dihydroxyphenylglycol to norepinephrine ratio in children with attention-deficit hyperactivity disorder (ADHD) treated with atomoxetine. | Journal of child neurology 20110101 |
| Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. | Neuroscience research 20110101 |
| European guidelines on managing adverse effects of medication for ADHD. | European child & adolescent psychiatry 20110101 |
| Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function. | Urologia internationalis 20110101 |
| Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder. | CNS drugs 20110101 |
| Cognitive enhancement by drugs in health and disease. | Trends in cognitive sciences 20110101 |
| Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. | Epilepsy & behavior : E&B 20110101 |
| Attention deficit hyperactivity disorder: part III. | Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 20110101 |
| Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. | Journal of the American Academy of Child and Adolescent Psychiatry 20110101 |
| Deepened extinction following compound stimulus presentation: noradrenergic modulation. | Learning & memory (Cold Spring Harbor, N.Y.) 20110101 |
| Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder. | BMC psychiatry 20110101 |
| Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation. | Neuropsychiatric disease and treatment 20110101 |
| The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. | BMC psychiatry 20110101 |
| A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design. | Trials 20110101 |
| Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial. | Clinical neuropharmacology 20110101 |
| Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day. | PloS one 20110101 |
| Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. | Neuropsychiatric disease and treatment 20110101 |
| A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder. | Indian journal of psychiatry 20110101 |
| Risperidone in the treatment of conduct disorder in preschool children without intellectual disability. | Child and adolescent psychiatry and mental health 20110101 |
| ADHD presenting as recurrent epistaxis: a case report. | Child and adolescent psychiatry and mental health 20110101 |
| Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies. | Child and adolescent psychiatry and mental health 20110101 |
| The 1287 G/A polymorphism of the norepinephrine transporter gene (NET) is involved in commission errors in Korean children with attention deficit hyperactivity disorder. | Behavioral and brain functions : BBF 20110101 |
| Antidepressant and antipsychotic use in an Italian pediatric population. | BMC pediatrics 20110101 |
| Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy. | Annals of Indian Academy of Neurology 20110101 |
| Noradrenaline and Parkinson's disease. | Frontiers in systems neuroscience 20110101 |
| Advances in understanding and treating ADHD. | BMC medicine 20110101 |
| Neurobiology of depression and anxiety in Parkinson's disease. | Parkinson's disease 20110101 |
| ADHD in children and adolescents. | BMJ clinical evidence 20110101 |
| Acupuncture for attention deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. | Trials 20110101 |
| The noradrenergic symptom cluster: clinical expression and neuropharmacology. | Neuropsychiatric disease and treatment 20110101 |
| Cardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 system. | Case reports in medicine 20110101 |
| Pharmacotherapy for fibromyalgia. | Frontiers in pharmacology 20110101 |
| Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. | BMC psychiatry 20110101 |
| Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents? | Child and adolescent psychiatry and mental health 20110101 |
| APRESS: apical regulatory super system, serotonin, and dopamine interaction. | Neuropsychiatric disease and treatment 20110101 |
| Animal models of attention-deficit/hyperactivity disorder. | Biological & pharmaceutical bulletin 20110101 |
| Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study. | Behavioral and brain functions : BBF 20110101 |
| Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder. | Annals of general psychiatry 20110101 |
| ADHD medication use, adherence, persistence and cost among Texas Medicaid children. | Current medical research and opinion 20110101 |
| Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial. | Current medical research and opinion 20110101 |
| Management of attention-deficit hyperactivity disorder. | Journal of pediatric neurosciences 20110101 |
| Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. | PloS one 20110101 |
| [Proposals for social policies to improve the quality of life in attention deficit/hyperactivity disorder [ADHD]]. | Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica 20110101 |
| Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. | Child and adolescent psychiatry and mental health 20110101 |
| Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. | BMC psychiatry 20110101 |
| Comorbidity and confounding factors in attention-deficit/hyperactivity disorder and sleep disorders in children. | Psychology research and behavior management 20110101 |
| Adults with attention-deficit/hyperactivity disorder - a brain magnetic resonance spectroscopy study. | Frontiers in psychiatry 20110101 |
| Patient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study. | Child and adolescent psychiatry and mental health 20110101 |
| Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants. | PloS one 20110101 |
| Monoamine depletion by reuptake inhibitors. | Drug, healthcare and patient safety 20110101 |
| Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder. | International journal of adolescent medicine and health 20110101 |
| The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies. | Neuropsychiatric disease and treatment 20110101 |
| A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD). | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101 |
| Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells. | Journal of psychopharmacology (Oxford, England) 20101201 |
| Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. | Environmental health perspectives 20101201 |
| Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. | Pharmacological research 20101201 |
| Attention deficit/hyperactivity disorder: a focused overview for children's environmental health researchers. | Environmental health perspectives 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Tuning arousal with optogenetic modulation of locus coeruleus neurons. | Nature neuroscience 20101201 |
| Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. | Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20101201 |
| Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists. | Seminars in pediatric neurology 20101201 |
| Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. | Seminars in pediatric neurology 20101201 |
| Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands. | Attention deficit and hyperactivity disorders 20101201 |
| The neuropharmacology of implicit learning. | Current neuropharmacology 20101201 |
| The genetic association between ADHD symptoms and reading difficulties: the role of inattentiveness and IQ. | Journal of abnormal child psychology 20101101 |
| Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. | The Journal of clinical psychiatry 20101101 |
| Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands. | Current medical research and opinion 20101101 |
| Atomoxetine for attention deficit hyperactivity disorder in mental retardation. | Pediatric neurology 20101101 |
| Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. | British journal of clinical pharmacology 20101101 |
| Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Methylphenidate significantly improves declarative memory functioning of adults with ADHD. | Psychopharmacology 20101001 |
| The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine. | Psychopharmacology 20101001 |
| Treatment of preschoolers with attention-deficit/hyperactivity disorder. | Current psychiatry reports 20101001 |
| Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders. | Current psychiatry reports 20101001 |
| Use of psychostimulants in patients with dementia. | The Annals of pharmacotherapy 20101001 |
| Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. | Drug safety 20101001 |
| The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. | CNS drugs 20101001 |
| Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. | Journal of the American Academy of Child and Adolescent Psychiatry 20101001 |
| EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20100901 |
| The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994-2003--a global pharmaceutical data analysis. | Health policy (Amsterdam, Netherlands) 20100901 |
| Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study. | Pharmacoepidemiology and drug safety 20100901 |
| Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD. | Current medical research and opinion 20100901 |
| Recognition of impaired atomoxetine metabolism because of low CYP2D6 activity. | Pediatric neurology 20100901 |
| Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? | Postgraduate medicine 20100901 |
| Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. | Postgraduate medicine 20100901 |
| Enhancing the salience of dullness: behavioral and pharmacological strategies to facilitate extinction of drug-cue associations in adolescent rats. | Neuroscience 20100825 |
| Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. | Neurology 20100803 |
| Attention deficit hyperactivity disorder in adults. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100801 |
| Post hoc analysis: early changes in ADHD-RS items predict longer term response to atomoxetine in pediatric patients. | Clinical pediatrics 20100801 |
| Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents. | Issues in mental health nursing 20100801 |
| Validation of the adult ADHD investigator symptom rating scale (AISRS). | Journal of attention disorders 20100701 |
| Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. | Journal of neurochemistry 20100701 |
| Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. | Clinical pharmacology and therapeutics 20100701 |
| Treatment of chronic akinetic mutism with atomoxetine: subtraction analysis of brain f-18 fluorodeoxyglucose positron emission tomographic images before and after medication: a case report. | Clinical neuropharmacology 20100701 |
| Electrochemical behavior of atomoxetine and its voltammetric determination in capsules. | Talanta 20100630 |
| Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. | Behavioural brain research 20100626 |
| Increasing CNS noradrenaline reduces EAE severity. | Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20100601 |
| A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. | The Journal of clinical psychiatry 20100601 |
| A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use. | European journal of clinical pharmacology 20100601 |
| Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100601 |
| Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. | CNS neuroscience & therapeutics 20100601 |
| Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells. | Journal of neural transmission (Vienna, Austria : 1996) 20100601 |
| Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20100601 |
| Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. | PLoS biology 20100601 |
| Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents. | Journal of child and adolescent psychopharmacology 20100601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100601 |
| Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder. | Attention deficit and hyperactivity disorders 20100601 |
| Atomoxetine's effect on societal costs in Sweden. | Journal of attention disorders 20100501 |
| Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. | Pharmacoepidemiology and drug safety 20100501 |
| Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. | British journal of pharmacology 20100501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100501 |
| Atomoxetine changes rat's HR response to stress from tachycardia to bradycardia via alterations in autonomic function. | Autonomic neuroscience : basic & clinical 20100419 |
| The role of the right inferior frontal gyrus: inhibition and attentional control. | NeuroImage 20100415 |
| Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. | European child & adolescent psychiatry 20100401 |
| Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. | Current medical research and opinion 20100401 |
| Real-World Data on: Attention Deficit Hyperactivity Disorder Medication Side Effects. | Psychiatry (Edgmont (Pa. : Township)) 20100401 |
| Quality of life and attention-deficit/hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. | Journal of clinical psychopharmacology 20100401 |
| Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. | Journal of neuroimmunology 20100330 |
| Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters. | European journal of pharmacology 20100310 |
| Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20100305 |
| Open-label trial of atomoxetine hydrochloride in adults with ADHD. | Journal of attention disorders 20100301 |
| Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine. | The international journal of neuropsychopharmacology 20100301 |
| [The health economics of attention deficit hyperactivity disorder in Germany. Part 2: Therapeutic options and their cost-effectiveness]. | Der Nervenarzt 20100301 |
| ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. | Upsala journal of medical sciences 20100301 |
| Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. | European child & adolescent psychiatry 20100301 |
| Principles of medical care for children with attention deficit hyperactivity disorder. | Neuroscience and behavioral physiology 20100301 |
| Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores. | Bioorganic & medicinal chemistry letters 20100301 |
| A current update on ADHD pharmacogenomics. | Pharmacogenomics 20100301 |
| Psychiatric pharmacogenomic testing in clinical practice. | Dialogues in clinical neuroscience 20100301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100301 |
| Academy of Medicine Singapore-Ministry of Health clinical practice guidelines: Autism Spectrum Disorders in pre-school children. | Singapore medical journal 20100301 |
| The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. | European child & adolescent psychiatry 20100201 |
| GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. | Psychopharmacology 20100201 |
| Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. | CNS drugs 20100201 |
| Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006. | Journal of child and adolescent psychopharmacology 20100201 |
| Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries. | PLoS medicine 20100201 |
| Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate. | Prescrire international 20100201 |
| Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine. | Psychiatry research 20100130 |
| Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study. | Journal of attention disorders 20100101 |
| Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. | European child & adolescent psychiatry 20100101 |
| Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. | Neuroscience and biobehavioral reviews 20100101 |
| Atomoxetine treatment for ADHD: younger adults compared with older adults. | Journal of attention disorders 20100101 |
| Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. | CNS drugs 20100101 |
| Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. | Drugs 20100101 |
| Occurrence and treatment of ADHD in adults. | CNS neuroscience & therapeutics 20100101 |
| Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. | CNS neuroscience & therapeutics 20100101 |
| Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. | Annals of general psychiatry 20100101 |
| Effects of atomoxetine on levels of monoamines and related substances in discrete brain regions in mice intermittently deprived of rapid eye movement sleep. | Biological & pharmaceutical bulletin 20100101 |
| Combining atomoxetine with carbamazepine or neuroleptics reduces adverse side effects. | Journal of paediatrics and child health 20100101 |
| Cerebellar mutism syndrome and its relation to cerebellar cognitive and affective function: Review of the literature. | Annals of Indian Academy of Neurology 20100101 |
| Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication. | Behavioral and brain functions : BBF 20100101 |
| Pharmacogenetic approach for a better drug treatment in children. | Current pharmaceutical design 20100101 |
| Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity Disorder: A systematic review. | Chiropractic & osteopathy 20100101 |
| Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade. | BMC research notes 20100101 |
| Nutritional status of children with attention deficit hyperactivity disorder: a pilot study. | International journal of pediatrics 20100101 |
| Central tetrahydrobiopterin concentration in neurodevelopmental disorders. | Frontiers in neuroscience 20100101 |
| Deficits in fine motor skills in a genetic animal model of ADHD. | Behavioral and brain functions : BBF 20100101 |
| European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. | BMC psychiatry 20100101 |
| Medical errors - I : The problem. | Indian journal of psychiatry 20100101 |
| Short cognitive behavioral therapy and cognitive training for adults with ADHD - a randomized controlled pilot study. | Neuropsychiatric disease and treatment 20100101 |
| Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines. | Neuropsychiatric disease and treatment 20100101 |
| Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer. | Clinical epidemiology 20100101 |
| Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study. | Lipids in health and disease 20100101 |
| Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula. | BMC psychiatry 20100101 |
| Development and validation of a stability-indicating RP-HPLC method for determination of atomoxetine hydrochloride in tablets. | Journal of AOAC International 20100101 |
| Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder. | Behavioral and brain functions : BBF 20100101 |
| A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. | The American journal on addictions 20100101 |
| Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. | Developmental disabilities research reviews 20100101 |
| Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support. | BMC bioinformatics 20100101 |
| Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials. | Child and adolescent psychiatry and mental health 20100101 |
| The neurobiological basis of ADHD. | Italian journal of pediatrics 20100101 |
| 3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders. | Scientia pharmaceutica 20100101 |
| Study protocol: the sleeping sound with attention-deficit/hyperactivity disorder project. | BMC pediatrics 20100101 |
| Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment. | GMS health technology assessment 20100101 |
| Patent protection strategies. | Journal of pharmacy & bioallied sciences 20100101 |
| Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. | Journal of pharmaceutical and biomedical analysis 20091205 |
| Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents. | European child & adolescent psychiatry 20091201 |
| Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. | Neuropharmacology 20091201 |
| Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD. | Neuropharmacology 20091201 |
| Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast. | Neuropharmacology 20091201 |
| The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. | Neuropharmacology 20091201 |
| Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20091201 |
| A randomized controlled trial of atomoxetine in generalized social anxiety disorder. | Journal of clinical psychopharmacology 20091201 |
| Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes. | British journal of pharmacology 20091201 |
| Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. | Expert review of neurotherapeutics 20091201 |
| Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study. | Journal of child and adolescent psychopharmacology 20091201 |
| Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder. | Journal of child and adolescent psychopharmacology 20091201 |
| Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study. | Journal of child and adolescent psychopharmacology 20091201 |
| Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20091201 |
| Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. | Attention deficit and hyperactivity disorders 20091201 |
| Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings. | Attention deficit and hyperactivity disorders 20091201 |
| Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091101 |
| Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder. | Current medical research and opinion 20091101 |
| The MTA at 8. | Journal of the American Academy of Child and Adolescent Psychiatry 20091101 |
| The MTA at 8. | Journal of the American Academy of Child and Adolescent Psychiatry 20091101 |
| Sensitivity of parent reports in the MTA. | Journal of the American Academy of Child and Adolescent Psychiatry 20091101 |
| [Tics and Tourette's syndrome throughout the life span]. | Der Nervenarzt 20091101 |
| Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders. | Postgraduate medicine 20091101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091101 |
| Pharmacologic mood destabilization: case vignettes. | CNS spectrums 20091101 |
| Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder. | Yonsei medical journal 20091031 |
| Current issues around the pharmacotherapy of ADHD in children and adults. | Pharmacy world & science : PWS 20091001 |
| Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
| Atomoxetine and cerebrovascular outcomes in adults. | Journal of clinical psychopharmacology 20091001 |
| Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease. | Journal of clinical psychopharmacology 20091001 |
| An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. | Journal of child and adolescent psychopharmacology 20091001 |
| An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. | Journal of child and adolescent psychopharmacology 20091001 |
| Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder. | Journal of child and adolescent psychopharmacology 20091001 |
| Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. | Health technology assessment (Winchester, England) 20091001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091001 |
| 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors. | Journal of medicinal chemistry 20090924 |
| Atomoxetine for freezing of gait in Parkinson disease. | Journal of the neurological sciences 20090915 |
| Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing. | Clinical pediatrics 20090901 |
| Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. | Journal of the American Academy of Child and Adolescent Psychiatry 20090901 |
| Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions. | CNS drugs 20090901 |
| Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study. | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20090901 |
| [Update on attention-deficit/hyperactive disorder treatment]. | Revista de neurologia 20090901 |
| The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. | Behavioural pharmacology 20090901 |
| [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20090901 |
| Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? | Psychiatria Danubina 20090901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090901 |
| Risperidone-induced sexual dysfunction in a prepubertal child - a case report. | Journal of psychopharmacology (Oxford, England) 20090801 |
| Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2). | European journal of nuclear medicine and molecular imaging 20090801 |
| Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study. | European child & adolescent psychiatry 20090801 |
| A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090801 |
| Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. | Psychopharmacology 20090801 |
| Acute effects of morphine on distinct forms of impulsive behavior in rats. | Psychopharmacology 20090801 |
| A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20090801 |
| Spatio-temporal clusters of new psychotropic medications among Michigan children insured by Medicaid. | Pharmacoepidemiology and drug safety 20090701 |
| Second opinions improve ADHD prescribing in a medicaid-insured community population. | Journal of the American Academy of Child and Adolescent Psychiatry 20090701 |
| [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem]. | Der Nervenarzt 20090701 |
| Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK. | International journal of clinical practice 20090701 |
| Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. | The international journal of neuropsychopharmacology 20090601 |
| Attention-deficit-hyperactivity disorder: an update. | Pharmacotherapy 20090601 |
| Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20090601 |
| Atomoxetine hydrochloride-associated transient psychosis in an adolescent with attention-deficit/hyperactivity disorder and mild mental retardation. | Journal of child and adolescent psychopharmacology 20090601 |
| High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. | Biological psychiatry 20090515 |
| Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study. | Journal of the American Academy of Child and Adolescent Psychiatry 20090501 |
| 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20090501 |
| [Drugs for attention deficit hyperactivity disorder]. | Revista de neurologia 20090501 |
| Is suicidality serious? | Current drug safety 20090501 |
| Pharmacotherapy for adult ADHD. | The Journal of clinical psychiatry 20090501 |
| Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting. | The American journal of managed care 20090501 |
| The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. | The American journal of managed care 20090501 |
| Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. | American family physician 20090415 |
| Norepinephrine and stimulant addiction. | Addiction biology 20090401 |
| Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. | Biological psychiatry 20090401 |
| Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. | European child & adolescent psychiatry 20090401 |
| How we say no: norepinephrine, inferior frontal gyrus, and response inhibition. | Biological psychiatry 20090401 |
| Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. | Expert review of neurotherapeutics 20090401 |
| InforMatrix for attention deficit hyperactivity disorder. | Expert opinion on pharmacotherapy 20090401 |
| A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. | The Journal of clinical psychiatry 20090401 |
| Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20090401 |
| Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20090401 |
| Two recent updates for psychiatric conditions. | Journal of child and adolescent psychopharmacology 20090401 |
| Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. | Journal of psychopharmacology (Oxford, England) 20090301 |
| Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder. | Expert opinion on pharmacotherapy 20090301 |
| Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls. | Journal of the American Academy of Child and Adolescent Psychiatry 20090301 |
| Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. | The British journal of psychiatry : the journal of mental science 20090301 |
| An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice. | Journal of pharmacological sciences 20090301 |
| Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. | Journal of child psychology and psychiatry, and allied disciplines 20090301 |
| Chinese slimming capsules containing sibutramine sold over the Internet: a case series. | Deutsches Arzteblatt international 20090301 |
| [Attention deficit hyperactivity disorder in adults]. | Revista de neurologia 20090227 |
| Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia. | Schizophrenia research 20090201 |
| Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. | Journal of clinical psychopharmacology 20090201 |
| Dopamine vs noradrenaline: inverted-U effects and ADHD theories. | The Australian and New Zealand journal of psychiatry 20090201 |
| Osmotically released methylphenidate is more effective than atomoxetine in children and adolescents with ADHD. | Evidence-based mental health 20090201 |
| Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD. | Journal of the American Academy of Child and Adolescent Psychiatry 20090201 |
| Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. | Movement disorders : official journal of the Movement Disorder Society 20090130 |
| [Without treatment the crash threatens]. | MMW Fortschritte der Medizin 20090129 |
| Enantioselective, ketoreductase-based entry into pharmaceutical building blocks: ethanol as tunable nicotinamide reductant. | Organic letters 20090115 |
| Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats. | Psychopharmacology 20090101 |
| Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys. | Psychopharmacology 20090101 |
| Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. | Journal of attention disorders 20090101 |
| Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats. | Drug metabolism and disposition: the biological fate of chemicals 20090101 |
| 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20090101 |
| Psychopharmacological treatment of oppositional defiant disorder. | CNS drugs 20090101 |
| Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. | Depression and anxiety 20090101 |
| Hemodynamic and cardiac neurotransmitter-releasing effects in conscious dogs of attention- and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone H3 inverse agonist. | Journal of cardiovascular pharmacology 20090101 |
| Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents. | British journal of pharmacology 20090101 |
| The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. | PloS one 20090101 |
| Worsening of bruxism with atomoxetine: a case report. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol. | Trials 20090101 |
| '...because I am something special' or 'I think I will be something like a guinea pig': information and assent of legal minors in clinical trials--assessment of understanding, appreciation and reasoning. | Child and adolescent psychiatry and mental health 20090101 |
| Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years. | Child and adolescent psychiatry and mental health 20090101 |
| Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. | Depression and anxiety 20090101 |
| Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies. | Child and adolescent psychiatry and mental health 20090101 |
| Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20090101 |
| Transcranial magnetic stimulation, synaptic plasticity and network oscillations. | Journal of neuroengineering and rehabilitation 20090101 |
| Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders. | CNS drugs 20090101 |
| The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned. | Child and adolescent psychiatry and mental health 20090101 |
| [Attention deficit hyperactivity syndrome: evolution, clinical presentations, treatment]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
| A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain. | BMC psychiatry 20090101 |
| Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. | Paediatric drugs 20090101 |
| Systematic review of interventions for children with Fetal Alcohol Spectrum Disorders. | BMC pediatrics 20090101 |
| A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD). | BMC health services research 20090101 |
| Attention deficit hyperactivity disorder in prison. | The journal of the American Academy of Psychiatry and the Law 20090101 |
| Once-daily medications for the pharmacological management of ADHD in adults. | Therapeutics and clinical risk management 20090101 |
| Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD. | Neuropsychiatric disease and treatment 20090101 |
| Psychopharmacology of ADHD in pediatrics: current advances and issues. | Neuropsychiatric disease and treatment 20090101 |
| Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. | Neuropsychiatric disease and treatment 20090101 |
| Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder. | Neuropsychobiology 20090101 |
| Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. | CNS drugs 20090101 |
| Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. | CNS drugs 20090101 |
| Nosologomania: DSM & Karl Jaspers' critique of Kraepelin. | Philosophy, ethics, and humanities in medicine : PEHM 20090101 |
| Treatment of obese patients with binge eating disorder using topiramate: a review. | Neuropsychiatric disease and treatment 20090101 |
| Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder. | Behavioral and brain functions : BBF 20090101 |
| Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment. | BMC health services research 20090101 |
| Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians. | Child and adolescent psychiatry and mental health 20090101 |
| Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride. | Neuropsychiatric disease and treatment 20090101 |
| [Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101 |
| A systematic review of augmentation strategies for patients with major depressive disorder. | Psychopharmacology bulletin 20090101 |
| Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090101 |
| Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. | Drug safety 20090101 |
| Actigraphic recording of manic symptoms induced by methylphenidate. | Case reports in medicine 20090101 |
| Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. | The American journal on addictions 20090101 |
| Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and adolescent psychiatry and mental health 20090101 |
| Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia. | Child and adolescent psychiatry and mental health 20090101 |
| Atomoxetine attenuates dextroamphetamine effects in humans. | The American journal of drug and alcohol abuse 20090101 |
| Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study. | The Israel journal of psychiatry and related sciences 20090101 |
| German experts cause controversy after calling for atomoxetine to be withdrawn. | BMJ (Clinical research ed.) 20081218 |
| Role of metabotropic glutamate receptor 5 in the procholinergic effects of neuropsychotherapeutic compounds. | Synapse (New York, N.Y.) 20081201 |
| Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20081201 |
| Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics. | Bioorganic & medicinal chemistry letters 20081201 |
| A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. | Journal of child and adolescent psychopharmacology 20081201 |
| [Raynaud phenomenon as adverse effect of ADHD treatment]. | Lakartidningen 20081201 |
| Neurophysiology of sleep and wakefulness: basic science and clinical implications. | Current neuropharmacology 20081201 |
| Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain. | Journal of medicinal chemistry 20081127 |
| Methylphenidate disrupts social play behavior in adolescent rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081101 |
| Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. | Journal of attention disorders 20081101 |
| Pharmacological manipulations of interval timing using the peak procedure in male C3H mice. | Psychopharmacology 20081101 |
| [ADHD in adults]. | Ugeskrift for laeger 20081020 |
| Free drug samples in the United States: characteristics of pediatric recipients and safety concerns. | Pediatrics 20081001 |
| Atomoxetine-induced mydriasis. | Journal of child and adolescent psychopharmacology 20081001 |
| Acute suicidality after commencing atomoxetine. | Journal of paediatrics and child health 20081001 |
| Attention-deficit-hyperactivity disorder and reward deficiency syndrome. | Neuropsychiatric disease and treatment 20081001 |
| Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. | BMJ (Clinical research ed.) 20080924 |
| Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors. | Bioorganic & medicinal chemistry letters 20080915 |
| Nucleophilic addition of phenol derivatives to methyl 1-nitrocyclopropanecarboxylates. | The Journal of organic chemistry 20080905 |
| Tricyclic antidepressants (TCA) may improve atomoxetine's efficacy. | The international journal of neuropsychopharmacology 20080901 |
| Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. | Psychopharmacology 20080901 |
| Abdominal Tics During Atomoxetine Treatment in a Child With ADHD: Evaluation and Differential Diagnosis. | CNS spectrums 20080901 |
| Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. | Current neuropharmacology 20080901 |
| Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. | Bioorganic & medicinal chemistry letters 20080815 |
| Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability. | Bioorganic & medicinal chemistry letters 20080815 |
| Characterisation and evaluation of UK websites on attention deficit hyperactivity disorder. | Archives of disease in childhood 20080801 |
| New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. | Pharmacology, biochemistry, and behavior 20080801 |
| Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder? | Archives of disease in childhood. Education and practice edition 20080801 |
| Combination of atomoxetine and methylphenidate in attention deficit/hyperactivity disorder: a case report. | Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20080801 |
| Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). | Bioorganic & medicinal chemistry letters 20080715 |
| Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness. | Sleep medicine 20080701 |
| Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. | Drug and alcohol dependence 20080701 |
| [What's new about hyperactivity disorder in children?]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20080701 |
| [Multimodal treatment of adult attention-deficit hyperactivity disorder]. | Der Nervenarzt 20080701 |
| [Multimodal treatment of attention-deficit hyperactivity disorder in children]. | Der Nervenarzt 20080701 |
| Atomoxetine-associated hemospermia: a case report. | The Journal of clinical psychiatry 20080701 |
| Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). | Journal of medicinal chemistry 20080612 |
| Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. | The American journal of psychiatry 20080601 |
| Both atomoxetine and stimulants improve quality of life in an ADHD population treated in a community clinic. | The Psychiatric quarterly 20080601 |
| Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat. | Basic & clinical pharmacology & toxicology 20080601 |
| Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors. | Bioorganic & medicinal chemistry letters 20080601 |
| Improving decision making in the treatment of ADHD. | The American journal of psychiatry 20080601 |
| Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. | The AAPS journal 20080601 |
| Narcolepsy: current treatment options and future approaches. | Neuropsychiatric disease and treatment 20080601 |
| Once-daily treatment of ADHD with guanfacine: patient implications. | Neuropsychiatric disease and treatment 20080601 |
| Functional outcomes in the treatment of adults with ADHD. | Journal of attention disorders 20080501 |
| The reliability and validity of self- and investigator ratings of ADHD in adults. | Journal of attention disorders 20080501 |
| ADHD in adults: a review of the literature. | Journal of attention disorders 20080501 |
| Abuse liability assessment of atomoxetine in a drug-abusing population. | Drug and alcohol dependence 20080501 |
| A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. | Current medical research and opinion 20080501 |
| Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. | Clinical therapeutics 20080501 |
| Pharmacotherapy of ADHD in adults. | CNS spectrums 20080501 |
| The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. | Current drug safety 20080501 |
| Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080401 |
| Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study. | Drug and alcohol dependence 20080401 |
| Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE). | Current medical research and opinion 20080401 |
| Psychopharmacological interventions. | Child and adolescent psychiatric clinics of North America 20080401 |
| Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. | Child and adolescent psychiatric clinics of North America 20080401 |
| The neuropharmacology of impulsive behaviour. | Trends in pharmacological sciences 20080401 |
| Human health risk assessments for three neuropharmaceutical compounds in surface waters. | Regulatory toxicology and pharmacology : RTP 20080401 |
| Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006. | Archives of disease in childhood. Education and practice edition 20080401 |
| Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. | International review of psychiatry (Abingdon, England) 20080401 |
| Development of tics in a thirteen-year-old male following atomoxetine use. | CNS spectrums 20080401 |
| Treatment of adults with attention-deficit/hyperactivity disorder. | Neuropsychiatric disease and treatment 20080401 |
| Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. | Psychopharmacology 20080301 |
| Emotional expression in children treated with ADHD medication: development of a new measure. | Journal of attention disorders 20080301 |
| Enhancement of atomoxetine serum levels by co-administration of paroxetine. | The international journal of neuropsychopharmacology 20080301 |
| Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury. | Journal of neurotrauma 20080301 |
| [Comment on the European guidelines for use of delayed action drugs for treatment of hyperkinetic disorders]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20080301 |
| [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20080301 |
| Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors. | Bioorganic & medicinal chemistry letters 20080215 |
| A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). | Journal of pharmaceutical and biomedical analysis 20080213 |
| CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080201 |
| Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. | Epilepsy & behavior : E&B 20080201 |
| Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. | Journal of the American Academy of Child and Adolescent Psychiatry 20080201 |
| Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatric treatment settings: a naturalistic study. | Current medical research and opinion 20080201 |
| Is NICE infallible? A qualitative study of its assessment of treatments for attention-deficit/hyperactivity disorder (ADHD). | Current medical research and opinion 20080201 |
| A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia. | Journal of clinical psychopharmacology 20080201 |
| Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. | The Journal of clinical psychiatry 20080201 |
| Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. | Pediatrics 20080201 |
| Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20080201 |
| Treatment of adults with attention-deficit/hyperactivity disorder. | Neuropsychiatric disease and treatment 20080201 |
| Treatment of adult ADHD: is current knowledge useful to clinicians? | Neuropsychiatric disease and treatment 20080201 |
| Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. | European journal of pharmacology 20080114 |
| Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. | Progress in neuro-psychopharmacology & biological psychiatry 20080101 |
| Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance. | Drug and alcohol dependence 20080101 |
| Medications do not necessarily normalize cognition in ADHD patients. | Journal of attention disorders 20080101 |
| Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. | Journal of attention disorders 20080101 |
| Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. | The Annals of pharmacotherapy 20080101 |
| Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence. | Paediatric drugs 20080101 |
| The NICE ADHD health technology assessment: a review and critique. | Child and adolescent psychiatry and mental health 20080101 |
| An 18-year-old woman with new-onset suicidal ideation while being treated with atomoxetine. | Journal of psychiatric practice 20080101 |
| l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). | Behavioral and brain functions : BBF 20080101 |
| Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan. | Malaria journal 20080101 |
| Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. | CNS drugs 20080101 |
| Pharmacological and therapeutic directions in ADHD: Specificity in the PFC. | Behavioral and brain functions : BBF 20080101 |
| Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes. | Medscape journal of medicine 20080101 |
| Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. | Drug safety 20080101 |
| Individual case safety reports in children in commonly used drug groups - signal detection. | BMC clinical pharmacology 20080101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20080101 |
| A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101 |
| Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day. | Child and adolescent psychiatry and mental health 20080101 |
| Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS). | Child and adolescent psychiatry and mental health 20080101 |
| A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. | Behavioral and brain functions : BBF 20080101 |
| Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician. | Primary care companion to the Journal of clinical psychiatry 20080101 |
| [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. | Child and adolescent psychiatry and mental health 20080101 |
| Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. | Child and adolescent psychiatry and mental health 20080101 |
| [Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. | Behavioral and brain functions : BBF 20080101 |
| Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. | Child and adolescent psychiatry and mental health 20080101 |
| Early head injury and attention deficit hyperactivity disorder: retrospective cohort study. | BMJ (Clinical research ed.) 20080101 |
| Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature. | BMC infectious diseases 20080101 |
| Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients. | General hospital psychiatry 20080101 |
| Recent developments and strategies in pediatric pharmacology research in the USA. | Child and adolescent psychiatry and mental health 20080101 |
| Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective. | Child and adolescent psychiatry and mental health 20080101 |
| [Atomoxetine (strattera) in the treatment of attention deficit hyperactivity syndrome]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| [Attention deficit hyperactivity disorder: clinical heterogeneity and possibilities of therapy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| [Principles of medical care for children with ADHD]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| [Electroencephalographic study of children with attention deficit hyperactivity disorder before and after treatment with strattera]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| ADHD in children and adolescents. | BMJ clinical evidence 20080101 |
| Development and validation of a HPTLC method for Estimation of Duloxetine Hydrochloride in Bulk Drug and in Tablet Dosage Form. | Indian journal of pharmaceutical sciences 20080101 |
| Preparation of antidepressants for use in preclinical research. | The international journal of neuropsychopharmacology 20071201 |
| Psychopharmacological treatment for very young children: contexts and guidelines. | Journal of the American Academy of Child and Adolescent Psychiatry 20071201 |
| Treatment of cognitive deficits in schizophrenia with atomoxetine: a case report. | The Journal of clinical psychiatry 20071201 |
| Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study. | Journal of child and adolescent psychopharmacology 20071201 |
| The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder--Child Version: psychometric properties of an adaptive change instrument. | Journal of child and adolescent psychopharmacology 20071201 |
| Effectiveness and tolerability of atomoxetine in a real-world ADHD population: nonrandomized comparison with stimulants. | Psychiatry (Edgmont (Pa. : Township)) 20071201 |
| Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. | Biological psychiatry 20071115 |
| Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. | Biological psychiatry 20071101 |
| Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20071101 |
| Changes and challenges: managing ADHD in a fast-paced world. | Journal of managed care pharmacy : JMCP 20071101 |
| Use of medication in children with psychiatric disorders. | Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association 20071101 |
| Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. | Psychopharmacology 20071001 |
| Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele. | British journal of clinical pharmacology 20071001 |
| Sleep disturbances and ADHD medications. | Current psychiatry reports 20071001 |
| Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications. | Experimental and clinical psychopharmacology 20071001 |
| Current issues and trends in the diagnosis and treatment of adults with ADHD. | Expert review of neurotherapeutics 20071001 |
| Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. | Journal of child and adolescent psychopharmacology 20071001 |
| [Prescribing of stimulants for ADHD in Nordland County]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070920 |
| Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070901 |
| An in vitro approach to potential methadone metabolic-inhibition interactions. | European journal of clinical pharmacology 20070901 |
| Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20070901 |
| High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. | Journal of the American Academy of Child and Adolescent Psychiatry 20070901 |
| Children with autism spectrum disorders and intellectual disability. | Current opinion in psychiatry 20070901 |
| Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies. | Journal of managed care pharmacy : JMCP 20070901 |
| Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. | Journal of managed care pharmacy : JMCP 20070901 |
| The consequences of attention-deficit/hyperactivity disorder in adults. | Journal of psychiatric practice 20070901 |
| Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders. | Pediatric annals 20070901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20070901 |
| [Atomoxetine (Strattera), an alternative in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children]. | L'Encephale 20070901 |
| A pharmacological analysis of stimulant-induced increases in smoking. | Psychopharmacology 20070801 |
| Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. | Drug metabolism and disposition: the biological fate of chemicals 20070801 |
| Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20070801 |
| When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment. | Expert review of neurotherapeutics 20070801 |
| The status of pharmacotherapy for autism spectrum disorders. | Expert opinion on pharmacotherapy 20070801 |
| Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. | Nuclear medicine and biology 20070801 |
| Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. | Journal of child and adolescent psychopharmacology 20070801 |
| A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20070801 |
| An atomoxetine tutorial. | Psychiatry (Edgmont (Pa. : Township)) 20070801 |
| Atomoxetine increases salivary cortisol in healthy volunteers. | Journal of psychopharmacology (Oxford, England) 20070701 |
| Determination of atomoxetine in human plasma by a high performance liquid chromatographic method with ultraviolet detection using liquid-liquid extraction. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701 |
| Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. | Hypertension (Dallas, Tex. : 1979) 20070701 |
| Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. | Developmental medicine and child neurology 20070701 |
| Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD. | Journal of attention disorders 20070701 |
| Management of attention-deficit/hyperactivity disorder. | British journal of hospital medicine (London, England : 2005) 20070701 |
| Exposure to attention deficit hyperactivity disorder medications during pregnancy. | Canadian family physician Medecin de famille canadien 20070701 |
| Dimensional analysis of ADHD subtypes in rats. | Biological psychiatry 20070615 |
| The neurobiology of attention-deficit/hyperactivity disorder. | Biological psychiatry 20070615 |
| Pediatric atomoxetine ingestions reported to Texas poison control centers, 2003-2005. | Journal of toxicology and environmental health. Part A 20070601 |
| The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19. | Journal of clinical psychopharmacology 20070601 |
| Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder? | Environmental health perspectives 20070601 |
| Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood. | Journal of child and adolescent psychopharmacology 20070601 |
| ADHD in children, adolescents, and adults. | Primary care 20070601 |
| Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. | Clinical therapeutics 20070601 |
| A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. | Neuropsychiatric disease and treatment 20070601 |
| [Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines]. | MMW Fortschritte der Medizin 20070521 |
| A new high performance liquid chromatographic method for quantification of atomoxetine in human plasma and its application for pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501 |
| Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. | Journal of the American Academy of Child and Adolescent Psychiatry 20070501 |
| Atomoxetine-induced hyponatremia. | The Australian and New Zealand journal of psychiatry 20070501 |
| Update on drugs for hyperactivity in childhood. | Drug and therapeutics bulletin 20070501 |
| A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran. | Progress in neuro-psychopharmacology & biological psychiatry 20070413 |
| Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. | Expert opinion on pharmacotherapy 20070401 |
| Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. | The Journal of clinical psychiatry 20070401 |
| A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20070401 |
| Non-stimulant trials of adult ADHD. | CNS spectrums 20070401 |
| Strattera: ups, downs, and emerging uses. | Psychiatry (Edgmont (Pa. : Township)) 20070401 |
| Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. | European journal of pharmacology 20070308 |
| [My child is so restless]. | MMW Fortschritte der Medizin 20070308 |
| A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. | Biological psychiatry 20070301 |
| Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. | Biological psychiatry 20070301 |
| Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. | Neuropharmacology 20070301 |
| Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action. | Neuropsychology review 20070301 |
| Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model. | Journal of proteome research 20070301 |
| Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. | The Journal of clinical psychiatry 20070301 |
| Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. | The Australian and New Zealand journal of psychiatry 20070301 |
| Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201 |
| Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. | Neuropharmacology 20070201 |
| Combined overdose of atomoxetine and methylphenidate in a cytochrome P450 2D6 poor metabolizer. | Journal of clinical psychopharmacology 20070201 |
| First case of sialolithiasis associated with atomoxetine. | Journal of clinical psychopharmacology 20070201 |
| A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. | Journal of attention disorders 20070201 |
| CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. | Journal of the American Academy of Child and Adolescent Psychiatry 20070201 |
| A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). | Current medical research and opinion 20070201 |
| Isolated atomoxetine overdose resulting in seizure. | The Journal of emergency medicine 20070201 |
| Emotional expression during attention-deficit/hyperactivity disorders treatment: initial assessment of treatment effects. | Journal of child and adolescent psychopharmacology 20070201 |
| Impaired cognition and attention in adults: pharmacological management strategies. | Neuropsychiatric disease and treatment 20070201 |
| Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. | Psychopharmacology 20070101 |
| Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. | Drug safety 20070101 |
| Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. | The British journal of psychiatry : the journal of mental science 20070101 |
| Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. | Journal of paediatrics and child health 20070101 |
| Effect of pioglitazone treatment on behavioral symptoms in autistic children. | Journal of neuroinflammation 20070101 |
| Atomoxetine-induced hepatitis in a child. | Clinical toxicology (Philadelphia, Pa.) 20070101 |
| Dyskinesias associated with atomoxetine in combination with other psychoactive drugs. | Clinical toxicology (Philadelphia, Pa.) 20070101 |
| Assessing the role of drugs in suicidal ideation and suicidality. | CNS drugs 20070101 |
| [Update in drug therapy in neuropediatry]. | Revue medicale de Liege 20070101 |
| Pharmacotherapy with atomoxetine for US children and adolescents. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
| A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder. | Child and adolescent psychiatry and mental health 20070101 |
| Baseline values from the electrocardiograms of children and adolescents with ADHD. | Child and adolescent psychiatry and mental health 20070101 |
| [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders]. | Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20070101 |
| Medicating young or very young patients--Part III. | Orthopedic nursing 20070101 |
| Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence. | Child and adolescent psychiatry and mental health 20070101 |
| [Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review]. | Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata 20070101 |
| [Disorders comorbid to attention deficit hyperactivity syndrome in children]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101 |
| Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder. | International journal of psychiatry in medicine 20070101 |
| Attention deficit hyperactivity disorder in adults. | Kathmandu University medical journal (KUMJ) 20070101 |
| Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. | European child & adolescent psychiatry 20061201 |
| Adult atomoxetine ingestions reported to Texas Poison Control Centers, 2003-2005. | The Annals of pharmacotherapy 20061201 |
| Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder. | Pediatrics 20061201 |
| Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. | Journal of clinical psychopharmacology 20061201 |
| Atomoxetine-induced electrocardiogram changes. | Archives of disease in childhood 20061201 |
| Pharmacological management of a youth with ADHD and a seizure disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20061201 |
| [Methylphenidate in the treatment of attention-deficit/hyperactivity disorder: are we achieving an adequate clinical practice?]. | Revista de neurologia 20061201 |
| Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis. | Journal of child and adolescent psychopharmacology 20061201 |
| Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? | Journal of child and adolescent psychopharmacology 20061201 |
| Effects of atomoxetine and methylphenidate on sleep in children with ADHD. | Sleep 20061201 |
| Atomoxetine: a novel treatment for child and adult ADHD. | Neuropsychiatric disease and treatment 20061201 |
| Antidepressants in the treatment of fibromyalgia. | Neuropsychiatric disease and treatment 20061201 |
| Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children. | Biological psychiatry 20061115 |
| Drugs for treatment of ADHD. | Treatment guidelines from the Medical Letter 20061101 |
| Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. | Clinical pediatrics 20061101 |
| Atomoxetine treating patients with Autistic disorder. | Autism : the international journal of research and practice 20061101 |
| Remission versus response as the goal of therapy in ADHD: a new standard for the field? | Clinical therapeutics 20061101 |
| Acute urinary retention associated with atomoxetine use. | The Australian and New Zealand journal of psychiatry 20061001 |
| Combination pharmacotherapy for adult ADHD. | Current psychiatry reports 20061001 |
| Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. | Psychiatric genetics 20061001 |
| Isolated atomoxetine (Strattera) ingestions commonly result in toxicity. | The Journal of emergency medicine 20061001 |
| Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. | Journal of the American Academy of Child and Adolescent Psychiatry 20061001 |
| Clinical inquiries. What are effective treatments for oppositional defiant behaviors in adolescents? | The Journal of family practice 20061001 |
| ADHD: new pharmacological treatments on the horizon. | Journal of developmental and behavioral pediatrics : JDBP 20061001 |
| Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. | Journal of child and adolescent psychopharmacology 20061001 |
| Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study. | Journal of child and adolescent psychopharmacology 20061001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20061001 |
| ADHD update: new data on the risks of medication. | The Harvard mental health letter 20061001 |
| Treatment of adult ADHD and comorbid disorders. | CNS spectrums 20061001 |
| Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with CYP2D6 metabolism. | Drug metabolism and disposition: the biological fate of chemicals 20060901 |
| The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder. | Neurobiology of disease 20060901 |
| Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20060901 |
| Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. | Psychopharmacology 20060901 |
| Is atomoxetine also effective in patients suffering from Tourette syndrome? | Journal of child neurology 20060901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060901 |
| Innovations and recent trends in the treatment of ADHD. | Expert review of neurotherapeutics 20060901 |
| Structural determination of the stable and meta-stable forms of atomoxetine HCl using single crystal and powder X-ray diffraction methods. | Journal of pharmaceutical sciences 20060801 |
| Dopamine transporter genotype influences the physiological response to medication in ADHD. | Brain : a journal of neurology 20060801 |
| Decreased use of clonidine following treatment with atomoxetine in children with ADHD. | Journal of clinical psychopharmacology 20060801 |
| Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20060801 |
| Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003. | Current medical research and opinion 20060801 |
| Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. | Expert review of pharmacoeconomics & outcomes research 20060801 |
| Pharmacotherapy of ADHD in young children. | Psychiatry (Edgmont (Pa. : Township)) 20060801 |
| Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial. | International journal of obesity (2005) 20060701 |
| A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. | Health technology assessment (Winchester, England) 20060701 |
| Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. | The Journal of pediatrics 20060701 |
| Psychopharmacology for the clinician. Treating depression with selective norepinephrine reuptake inhibitors. | Journal of psychiatry & neuroscience : JPN 20060701 |
| Atomoxetine. | Indian pediatrics 20060701 |
| Determination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phases. | Journal of pharmaceutical and biomedical analysis 20060616 |
| A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials. | Journal of pharmaceutical and biomedical analysis 20060616 |
| Adjunctive atomoxetine for residual fatigue in major depressive disorder. | Journal of psychiatric research 20060601 |
| The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20060601 |
| Pharmacological treatment of attention-deficit/hyperactivity disorder in adults. | Expert opinion on investigational drugs 20060601 |
| Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. | The Annals of pharmacotherapy 20060601 |
| Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. | Journal of child and adolescent psychopharmacology 20060601 |
| Severe liver injury after initiating therapy with atomoxetine in two children. | The Journal of pediatrics 20060601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060601 |
| Somatic symptoms in depression. | Dialogues in clinical neuroscience 20060601 |
| Attention deficit hyperactivity disorder in children. | Clinical evidence 20060601 |
| The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination. | Therapeutics and clinical risk management 20060601 |
| Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. | Neuropharmacology 20060501 |
| The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. | Journal of psychiatry & neuroscience : JPN 20060501 |
| [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization]. | Revista de neurologia 20060501 |
| Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. | Experimental and clinical psychopharmacology 20060501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060501 |
| Attention deficit/hyperactivity disorder: complexities and controversies. | Current opinion in pediatrics 20060401 |
| Factors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims data. | Journal of managed care pharmacy : JMCP 20060401 |
| Major Depression with ADHD: In Children and Adolescents. | Psychiatry (Edgmont (Pa. : Township)) 20060401 |
| [The effectiveness of atomoxetine in children, adolescents, and adults with ADHD. A systematic overview]. | Der Nervenarzt 20060301 |
| A comparison of North American versus non-North American ADHD study populations. | European child & adolescent psychiatry 20060301 |
| Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. | European child & adolescent psychiatry 20060301 |
| Close up on atomoxetine: a nonstimulant choice for treating ADHD. | Advance for nurse practitioners 20060301 |
| Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report. | Pharmacopsychiatry 20060301 |
| ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. | Dialogues in clinical neuroscience 20060301 |
| Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. | The Journal of clinical psychiatry 20060301 |
| [Treatment of attention deficit/hyperactivity disorder]. | La Revue du praticien 20060227 |
| Neurochemical modulation of response inhibition and probabilistic learning in humans. | Science (New York, N.Y.) 20060210 |
| [Atomoxetine in the treatment of ADHD]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060209 |
| [Atomoxetine--an addition]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060209 |
| Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060201 |
| Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. | Molecular psychiatry 20060201 |
| Do children and adolescents with ADHD respond differently to atomoxetine? | Journal of the American Academy of Child and Adolescent Psychiatry 20060201 |
| Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo. | Evidence-based mental health 20060201 |
| Atomoxetine enhances a short-term model of plasticity in humans. | Archives of physical medicine and rehabilitation 20060201 |
| Absence of unfavorable effect of atomoxetine on growth in pediatric patients is still not demonstrated. | Pediatrics 20060201 |
| Nonstimulant medications for the treatment of ADHD. | Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 20060201 |
| Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary. | European child & adolescent psychiatry 20060201 |
| A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. | Clinical therapeutics 20060201 |
| Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. | Child and adolescent psychiatric clinics of North America 20060101 |
| Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. | Psychosomatics 20060101 |
| Postmortem tissue distribution of atomoxetine following fatal and nonfatal doses--three case reports. | Journal of forensic sciences 20060101 |
| New developments in the treatment of ADHD. | The Journal of clinical psychiatry 20060101 |
| Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis. | Behavioral and brain functions : BBF 20060101 |
| Atomoxetine for individuals with traumatic brain injury. | The Journal of head trauma rehabilitation 20060101 |
| Children and adolescent exposures to atomoxetine hydrochloride reported to a poison control center. | Clinical toxicology (Philadelphia, Pa.) 20060101 |
| Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101 |
| Misuse of 'study drugs:' prevalence, consequences, and implications for policy. | Substance abuse treatment, prevention, and policy 20060101 |
| The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. | Molecular diagnosis & therapy 20060101 |
| Potential interactions of methylphenidate and atomoxetine with dextromethorphan. | Journal of the American Pharmacists Association : JAPhA 20060101 |
| Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. | Behavioral and brain functions : BBF 20060101 |
| The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management. | Indian pacing and electrophysiology journal 20060101 |
| Mechanism of action of agents used in attention-deficit/hyperactivity disorder. | The Journal of clinical psychiatry 20060101 |
| Primary care treatment of attention-deficit/hyperactivity disorder. | The Journal of clinical psychiatry 20060101 |
| [An integrative approach of attention deficit in adolescence]. | Vertex (Buenos Aires, Argentina) 20060101 |
| Clinical review: evidence-based diagnosis and treatment of ADHD in children. | Missouri medicine 20060101 |
| [Atomoxetine--Strattera. Oral preparation]. | Journal de pharmacie de Belgique 20060101 |
| Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. | Neurology 20051227 |
| Suicidal ideation among children taking atomoxetine (Strattera). | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20051206 |
| Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. | Journal of child and adolescent psychopharmacology 20051201 |
| Attention deficit hyperactivity disorder--a review for family physicians. | Indian journal of medical sciences 20051201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051201 |
| Managing adverse reactions to psychotropic medications. | Pediatric annals 20051201 |
| What is the significance of the new warnings about suicide risk with Strattera? | The Harvard mental health letter 20051201 |
| Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder. | Pharmacotherapy 20051101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051101 |
| Pharmacologic treatment of attention-deficit hyperactivity disorder. | Indian journal of pediatrics 20051101 |
| Hyperactivity really IS common...and a new warning about treatment. | Child health alert 20051101 |
| Perspectives in psychopharmacology: spotlight on atomoxetine. | The Canadian child and adolescent psychiatry review = La revue canadienne de psychiatrie de l'enfant et de l'adolescent 20051101 |
| [Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder]. | Revista de neurologia 20051001 |
| Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants. | The Journal of clinical psychiatry 20051001 |
| Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. | Journal of the National Medical Association 20051001 |
| Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. | The international journal of neuropsychopharmacology 20050901 |
| Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. | Journal of the American Academy of Child and Adolescent Psychiatry 20050901 |
| The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. | Dialogues in clinical neuroscience 20050901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050901 |
| Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography. | Sleep 20050901 |
| Atomoxetine also effective in patients suffering from narcolepsy? | Sleep 20050901 |
| Advances in alternative pharmacotherapy of ADHD. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050901 |
| Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial. | Neuropsychiatric disease and treatment 20050901 |
| Righting a troubled course. Diagnosing and treating ADHD in adults. | Advance for nurse practitioners 20050801 |
| [Attention deficit hyperactivity disorder: pharmacological options that are not 'Ritalin']. | Harefuah 20050801 |
| Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20050801 |
| A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. | Journal of attention disorders 20050801 |
| Simultaneous quantification of atomoxetine as well as its primary oxidative and O-glucuronide metabolites in human plasma and urine using liquid chromatography tandem mass spectrometry (LC/MS/MS). | Journal of pharmaceutical and biomedical analysis 20050715 |
| Emotional dysregulation in adult ADHD and response to atomoxetine. | Biological psychiatry 20050715 |
| Hemodynamic effects of acute administration of atomoxetine and methylphenidate. | Journal of clinical pharmacology 20050701 |
| A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. | Journal of the American Academy of Child and Adolescent Psychiatry 20050701 |
| Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. | Pediatrics 20050701 |
| Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. | Expert review of neurotherapeutics 20050701 |
| Atomoxetine ingestions in children: a report from poison centers. | The Annals of pharmacotherapy 20050601 |
| Increased blood pressure and atomoxetine. | Journal of the American Academy of Child and Adolescent Psychiatry 20050601 |
| The answerable question and a hierarchy of evidence. | Journal of the American Academy of Child and Adolescent Psychiatry 20050601 |
| Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. | Pediatrics 20050601 |
| Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. | Pediatrics 20050601 |
| Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. | Archives of pediatrics & adolescent medicine 20050601 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050601 |
| Attention deficit hyperactivity disorder in children. | Clinical evidence 20050601 |
| Emerging therapies in narcolepsy-cataplexy. | Sleep 20050601 |
| Atomoxetine in the treatment of patients with ADHD. | American family physician 20050515 |
| Pharmacotherapy of adult ADHD. | Journal of clinical psychology 20050501 |
| Atomoxetine and tics in ADHD. | Journal of the American Academy of Child and Adolescent Psychiatry 20050501 |
| Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine: a comparison of parents and teachers as informants. | Journal of attention disorders 20050501 |
| Support for association between ADHD and two candidate genes: NET1 and DRD1. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050405 |
| DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050405 |
| Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050401 |
| Update: attention deficit/hyperactivity disorder in the primary care office. | Current opinion in pediatrics 20050401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050401 |
| Atomoxetine hydrochloride and executive function in children with attention-deficit/hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20050401 |
| Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. | Journal of child and adolescent psychopharmacology 20050401 |
| Atomoxetine use associated with onset of a motor tic. | Journal of child and adolescent psychopharmacology 20050401 |
| Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20050401 |
| Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20050401 |
| Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice. | Neuroscience letters 20050329 |
| Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20050301 |
| Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. | Journal of the American Academy of Child and Adolescent Psychiatry 20050301 |
| Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. | The Journal of clinical psychiatry 20050301 |
| The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. | Expert opinion on drug safety 20050301 |
| Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant? | Neuropsychiatric disease and treatment 20050301 |
| A new paradigm for developing drugs in children: atomoxetine as a model. | Archives of disease in childhood 20050201 |
| Managing attention deficit/hyperactivity disorder: unmet needs and future directions. | Archives of disease in childhood 20050201 |
| Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. | Archives of disease in childhood 20050201 |
| Training raters to assess adult ADHD: reliability of ratings. | Journal of attention disorders 20050201 |
| Attention deficit disorder and epilepsy. | Pediatric neurology 20050101 |
| [Atomoxetine safety and efficacy in children with attention deficit/hyperactivity disorder (ADHD): initial phase of 10-week treatment in a relapse prevention study with a Spanish sample]. | Actas espanolas de psiquiatria 20050101 |
| Benign clinical course following atomoxetine overdose. | Clinical toxicology (Philadelphia, Pa.) 20050101 |
| Treatment of attention deficit hyperactivity disorder in adults. | Expert review of neurotherapeutics 20050101 |
| Clinical pharmacokinetics of atomoxetine. | Clinical pharmacokinetics 20050101 |
| [The entire day counts]. | Krankenpflege Journal 20050101 |
| Animal models of attention-deficit hyperactivity disorder. | Behavioral and brain functions : BBF 20050101 |
| Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications. | CNS drugs 20050101 |
| New warning about ADHD drug. | FDA consumer 20050101 |
| [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]. | L'Encephale 20050101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050101 |
| Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. | Behavioral and brain functions : BBF 20050101 |
| Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults. | Essential psychopharmacology 20050101 |
| Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD). | Essential psychopharmacology 20050101 |
| Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths. | Theoretical biology & medical modelling 20050101 |
| Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. | Advances in therapy 20050101 |
| [Creutzfeld Disease Innovation Award]. | Krankenpflege Journal 20050101 |
| Warning on Strattera for attention-deficit hyperactivity disorder. | FDA consumer 20050101 |
| Attention deficit/hyperactivity disorder: pharmacotherapy. | Psychiatry (Edgmont (Pa. : Township)) 20050101 |
| Comment on 'Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine'. | Journal of developmental and behavioral pediatrics : JDBP 20041201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041201 |
| Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder. | Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20041201 |
| Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041115 |
| Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication. | The Journal of clinical psychiatry 20041101 |
| New drugs for the treatment of attention-deficit/hyperactivity disorder. | Expert opinion on emerging drugs 20041101 |
| Mania induction associated with atomoxetine. | Journal of clinical psychopharmacology 20041001 |
| [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder]. | Fortschritte der Neurologie-Psychiatrie 20041001 |
| A lifetime of distractions. ADHD is no longer just a children's disease. Many adults are being diagnosed and treated for the condition. | Harvard health letter 20041001 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041001 |
| Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder. | Journal of attention disorders 20041001 |
| Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. | Drug and alcohol dependence 20040906 |
| Atomoxetine and tics in ADHD. | Journal of the American Academy of Child and Adolescent Psychiatry 20040901 |
| Atomoxetine and nonresponders to stimulants. | The American journal of psychiatry 20040901 |
| Aggression, mania, and hypomania induction associated with atomoxetine. | Pediatrics 20040901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040901 |
| Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. | Seminars in pediatric neurology 20040901 |
| Atomoxetine (Strattera) revisited. | The Medical letter on drugs and therapeutics 20040816 |
| Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial kappa-opioid agonist effect. | Bioorganic & medicinal chemistry letters 20040802 |
| Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine. | Journal of developmental and behavioral pediatrics : JDBP 20040801 |
| Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. | Pharmacotherapy 20040801 |
| Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. | Progress in neuro-psychopharmacology & biological psychiatry 20040801 |
| A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. | European child & adolescent psychiatry 20040801 |
| Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. | Journal of the American Academy of Child and Adolescent Psychiatry 20040701 |
| Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. | Pediatrics 20040701 |
| Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action. | The American journal of managed care 20040701 |
| New options in the pharmacological management of attention-deficit/hyperactivity disorder. | The American journal of managed care 20040701 |
| The use of atomoxetine adjunctively in fibromyalgia syndrome. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040701 |
| Atomoxetine in the treatment of attention deficit hyperactivity disorder. | Expert review of neurotherapeutics 20040701 |
| Driving impairments in teens and adults with attention-deficit/hyperactivity disorder. | The Psychiatric clinics of North America 20040601 |
| Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. | The Psychiatric clinics of North America 20040601 |
| Pharmacological management of attention-deficit hyperactivity disorder. | Expert opinion on pharmacotherapy 20040601 |
| Acute oxcarbazepine and atomoxetine overdose with quetiapine. | Veterinary and human toxicology 20040601 |
| The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. | Journal of developmental and behavioral pediatrics : JDBP 20040601 |
| Adrenergic alpha 2C receptor genomic organization: association study in adult ADHD. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20040515 |
| Potential noradrenergic targets for cognitive enhancement in schizophrenia. | CNS spectrums 20040501 |
| Atomoxetine hydrochloride. | Nature reviews. Drug discovery 20040501 |
| Atomoxetine--treatment of attention deficit hyperactivity disorder: beyond stimulants. | Drugs of today (Barcelona, Spain : 1998) 20040501 |
| Seizures and prolonged QTc with atomoxetine overdose. | The American journal of psychiatry 20040401 |
| Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. | The international journal of neuropsychopharmacology 20040301 |
| Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome. | The Journal of pharmacology and experimental therapeutics 20040201 |
| Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. | Journal of clinical psychopharmacology 20040201 |
| New drugs 04, part 1. | Nursing 20040201 |
| [New therapeutic options in the treatment of attention deficit/hyperactivity disorder]. | Revista de neurologia 20040201 |
| [Tourette syndrome: an analysis of its comorbidity and specific treatment]. | Revista de neurologia 20040201 |
| No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20040101 |
| [Medical treatments of hyperactive child]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20040101 |
| Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. | Drugs 20040101 |
| Atomoxetine treatment of attention-deficit/hyperactivity disorder. | The Annals of pharmacotherapy 20040101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
| [Attention-deficit/hyperactivity disorder (ADHS) in adulthood]. | Psychotherapie, Psychosomatik, medizinische Psychologie 20040101 |
| ADHD treatment across the life cycle. | The Journal of clinical psychiatry 20040101 |
| Impact of ADHD and its treatment on substance abuse in adults. | The Journal of clinical psychiatry 20040101 |
| Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder. | CNS drugs 20040101 |
| New drugs of 2003. | Journal of the American Pharmacists Association : JAPhA 20040101 |
| Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. | Journal of child and adolescent psychopharmacology 20040101 |
| Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. | Neural plasticity 20040101 |
| Non-stimulant medications in the treatment of ADHD. | European child & adolescent psychiatry 20040101 |
| Atomoxetine for the treatment of pediatric nocturnal enuresis. | Journal of child and adolescent psychopharmacology 20040101 |
| Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake. | Bioorganic & medicinal chemistry letters 20031215 |
| First new ADHD treatment in 30 years. | The Nurse practitioner 20031201 |
| Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. | Clinical therapeutics 20031201 |
| Atomoxetine for ADHD. | American family physician 20031101 |
| Synthesis and pharmacological evaluation of (Z)-9-(heteroarylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes: thiophene analogues as potent norepinephrine transporter inhibitors. | Bioorganic & medicinal chemistry letters 20031020 |
| Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. | Psychopharmacology 20030901 |
| The use of antidepressants to treat attention deficit hyperactivity disorder in adults. | Journal of psychopharmacology (Oxford, England) 20030901 |
| Atomoxetine and pregnancy. | Journal of the American Academy of Child and Adolescent Psychiatry 20030801 |
| Pharmacological treatments for ADHD and the novel agent atomoxetine. | Journal of psychosocial nursing and mental health services 20030801 |
| Treating adolescents for substance abuse and comorbid psychiatric disorders. | Science & practice perspectives 20030801 |
| Response: adolescent substance abuse patients: resilience and complexity. | Science & practice perspectives 20030801 |
| Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. | Expert opinion on pharmacotherapy 20030701 |
| Atomoxetine for attention deficit/hyperactivity disorder. | Issues in emerging health technologies 20030501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030501 |
| Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome. | Current opinion in pediatrics 20030401 |
| Non-stimulant treatment of attention-deficit/hyperactivity disorder. | CNS spectrums 20030401 |
| Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. | Child and adolescent psychiatric clinics of North America 20030401 |
| Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites. | Clinical pharmacology and therapeutics 20030301 |
| Atomoxetine (strattera) for ADHD. | The Medical letter on drugs and therapeutics 20030203 |
| Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition. | The Journal of clinical psychiatry 20030201 |
| Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. | Biological psychiatry 20030115 |
| Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog. | Drug metabolism and disposition: the biological fate of chemicals 20030101 |
| Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. | Drug metabolism and disposition: the biological fate of chemicals 20030101 |
| Strattera approved to treat ADHD. | FDA consumer 20030101 |
| Atomoxetine. | Paediatric drugs 20030101 |
| Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20030101 |
| Cardiovascular effects of atomoxetine in children, adolescents, and adults. | Drug safety 20030101 |
| Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. | The Journal of clinical psychiatry 20030101 |
| Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. | Pediatrics 20021201 |
| Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. | The Journal of clinical psychiatry 20021201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021201 |
| Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. | The American journal of psychiatry 20021101 |
| Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. | Journal of clinical pharmacology 20021101 |
| Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021101 |
| Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. | Neuroscience letters 20020809 |
| Drugs under investigation for attention-deficit hyperactivity disorder. | Current opinion in investigational drugs (London, England : 2000) 20020801 |
| Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. | Drug and alcohol dependence 20020701 |
| Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. | Journal of the American Academy of Child and Adolescent Psychiatry 20020701 |
| The norepinephrine transporter gene and attention-deficit hyperactivity disorder. | American journal of medical genetics 20020408 |
| Identification of the human cytochromes P450 responsible for atomoxetine metabolism. | Drug metabolism and disposition: the biological fate of chemicals 20020301 |
| Tomoxetine (Eli Lilly & Co). | Current opinion in investigational drugs (London, England : 2000) 20020201 |
| Overview and neurobiology of attention-deficit/hyperactivity disorder. | The Journal of clinical psychiatry 20020101 |
| Novel treatments for attention-deficit/hyperactivity disorder in children. | The Journal of clinical psychiatry 20020101 |
| Drug development process for a product with a primary pediatric indication. | The Journal of clinical psychiatry 20020101 |
| Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. | The Journal of clinical psychiatry 20020101 |
| Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. | Journal of child and adolescent psychopharmacology 20020101 |
| Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder. | Journal of attention disorders 20020101 |
| Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. | Pediatrics 20011101 |
| New treatments and approaches for attention deficit hyperactivity disorder. | Current psychiatry reports 20010401 |
| An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20010101 |
| An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. | Journal of child and adolescent psychopharmacology 20010101 |
| Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group. | Bioorganic & medicinal chemistry letters 19980303 |